Relationship between the severity of endothelial dysfunction and metabolic disorders and the severity of climacteric syndrome
- Authors: Tolstov S.N.1,2, Salov I.A.1, Rebrov A.P.1
-
Affiliations:
- V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
- Regional Clinical Cardiological Dispensary
- Issue: No 8 (2021)
- Pages: 119-126
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249408
- DOI: https://doi.org/10.18565/aig.202L8.n9-126
- ID: 249408
Cite item
Abstract
Full Text
About the authors
Sergey N. Tolstov
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia; Regional Clinical Cardiological Dispensary
Email: tolstovsn@mail.ru
Dr. Med. Sci., Professor of the Department of Therapy with Courses in Cardiology, Functional diagnostics and Geriatrics Saratov, Russia
Igor A. Salov
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Email: salov.i.a@mail.ru
Dr. Med. Sci., Professor, Head of Оbstetrics and Gynecology Department Saratov, Russia
Andrey P. Rebrov
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Email: andreyrebrov@yandex.ru
Dr. Med. Sci., Professor, Head of Hospital Therapy Department Saratov, Russia
References
- Newson L. Menopause and cardiovascular disease. Post Reprod. Health. 2018; 24(1): 44-9. https://dx.doi.org/10.1177/2053369117749675.
- Baber R.J., Panay N., Fenton A.; IMS Writing Group. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016; 19(2): 109-50. https://dx.doi.org/10.3109/13697137.2015.1129166.
- Юренева С.В., Ильина Л.М., Сметник В.П. Старение репродуктивной системы женщин: от теории к клинической практике. Часть I. Эндокринные и клинические характеристики стадий репродуктивного старения женщин. Акушерство и гинекология. 2014; 3: 21-7.
- Pinkerton J.V. Hormone therapy for postmenopausal women. N. Engl. J. Med. 2020; 382(5): 446-55. https://dx.doi.org/10.1056/NEJMcp1714787.
- Avis N.E., Crawford S.L., Greendale G., Bromberger J.T., Everson-Rose S.A., Gold E.B. et al. Study of Women's Health Across the Nation. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern. Med. 2015; 175(4): 531-9. https://dx.doi.org/10.1001/jamainternmed.2014.8063.
- Collins P., Webb C.M., de Villiers T.J., Stevenson J.C., Panay N., Baber R.J. Cardiovascular risk assessment in women - an update. Climacteric. 2016; 19(4): 329-36. https://dx.doi.org/10.1080/13697137.2016.1198574.
- Thurston R.C. Vasomotor symptoms: natural history, physiology, and links with cardiovascular health. Climacteric. 2018; 21(2): 96-100. https://dx.doi.org/10.1080/13697137.2018.1430131.
- Gast G.C., Pop V.J., Samsioe G.N., Grobbee D.E., Nilsson P.M., Keyzer J.J. et al. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause. 2011; 18(2): 146-51.
- Biglia N., Cagnacci A., Gambacciani M., Lello S., Maffei S., Nappi R.E. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017; 20(4): 306-12. https://dx.doi.org/10.1080/13697137.2017.1315089.
- Tuomikoski P., Savolainen-Peltonen H. Vasomotor symptoms and metabolic syndrome. Maturitas. 2017; 97: 61-5. https://dx.doi.org/10.1016/j.maturitas.2016.12.010.
- Svartberg J., von Mühlen D., Kritz-Silverstein D., Barrett-Connor E. Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause. 2009; 16(5): 888-91. https://dx.doi.org/10.1097/gme.0b013e3181a4866b.
- Dam V., Dobson A.J., Onland-Moret N.C., van der Schouw Y.T., Mishra G.D. Vasomotor menopausal symptoms and cardiovascular disease risk in midlife: A longitudinal study. Maturitas. 2020; 133: 32-41. https://dx.doi.org/10.1016/j.maturitas.2019.12.011.
- Muka T., Oliver-Williams C., Colpani V., Kunutsor S., Chowdhury S., Chowdhury R. et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: a systematic review and meta-analysis. PLoS One. 2016; 11(6): e0157417. https://dx.doi.org/10.1371/journal.pone.0157417.
- Szmuilowicz E.D., Manson J.E., Rossouw J.E., Howard B.V., Margolis K.L, Greep N.C. et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause. 2011; 18(6): 603-10. https://dx.doi.org/10.1097/gme.0b013e3182014849.
- Harlow S.D., Gass M., Hall J.E., Lobo R., Maki P., Rebar R.W. et al.; STRAW 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012; 19(4): 387-95. https://dx.doi.org/10.1097/gme.0b013e31824d8f40.
- Вихляева Е.М. Руководство по эндокринной гинекологии. М.: МИА; 2006. 784с.
- Tuomikoski P., Ebert P., Groop P.H., Haapalahti P., Hautamäki H., Rönnback M. et al. Effect of hot flushes on vascular function: a randomized controlled trial. Obsteto Gynecol. 2009; 114(4): 777-85. https://dx.doi.org/10.1097/AOG.0b013e3181b6f268.
- Martinez Perez J.A., Palacios S., Chavida F., Perez M. Severity of menopausal symptoms and cardiovascular and osteoporosis risk factors. Climacteric. 2013; 16(2): 226-34. https://dx.doi.org/10.3109/13697137.2012.688077.
- Zhu D., Chung H.F., Dobson A.J., Pandeya N., Anderson D.J., Kuh D. et al. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Am. J. Obstet. Gynecol. 2020; 223(6): 898. e1-898. e16. https://dx.doi.org/10.1016/j.ajog.2020.06.039.
- Kaya C., Cengiz H., Ye§il A., Ekin M., Yasar L. The relation among steroid hormone levels, lipid profile and menopausal symptom severity. J. Psychosom. Obste.t Gynaecol. 2017; 38(4): 284-91. https://dx.doi.org/10.1080/0167482X.2017.1321633.
- Thurston R.C., Chang Y., Barinas-Mitchell E., Jennings J.R., von Känel R., Landsittel D.P. et al. Physiologically assessed hot flashes and endothelial function among midlife women. Menopause. 2018; 25(11): 1354-61. https://dx.doi.org/10.1097/GME.0000000000001239.